Ли Ноу - Эгоистичная митохондрия. Как сохранить здоровье и отодвинуть старость
- Название:Эгоистичная митохондрия. Как сохранить здоровье и отодвинуть старость
- Автор:
- Жанр:
- Издательство:Питер
- Год:2020
- Город:Санкт-Петербург
- ISBN:978-5-4461-1021-6
- Рейтинг:
- Избранное:Добавить в избранное
-
Отзывы:
-
Ваша оценка:
Ли Ноу - Эгоистичная митохондрия. Как сохранить здоровье и отодвинуть старость краткое содержание
В нашем организме работают крошечные «энергетические станции» — митохондрии. Именно они отвечают за наше здоровье и отличное самочувствие. Когда они работают хорошо, мы не испытываем недостатка в энергии. А когда плохо — страдаем от заболеваний. Доктор Ли Ноу открывает тайну: заболевания, которые кажутся не связанными между собой на первый взгляд: диабет, рак, шизофрения, хроническая усталость, болезнь Паркинсона и другие — имеют общую природу.
Сегодня нам известно, как улучшить работу митохондрий, обеспечивающих организм энергией на 90 %. В этой книге вас ждет актуальная информация о питании, образе жизни, кетогенной диете и добавках, которые возвращают здоровье митохондриям, а следовательно, и нам.
Эгоистичная митохондрия. Как сохранить здоровье и отодвинуть старость - читать онлайн бесплатно ознакомительный отрывок
Интервал:
Закладка:
Morales C. R., et al. Oxidative stress and autophagy in cardiovascular homeostasis. Antioxid Redox Signal. 2014 Jan 20; 20(3):507–518. Epub 2013 May 5. doi:10.1089/ars.2013.5359.
Nazarewicz R. R., Dikalov S. I. Mitochondrial ROS in the pro-hypertensive immune response. Am J Physiol Regul Integr Comp Physiol. 2013 May 8; 305:R98–100. Epub. doi:10.1152 /ajpregu.00208.2013.
Oeseburg H., et al. Bradykinin protects against oxidative stress-induced endothelial cell senescence. Hypertension. 2009 Feb; 53(Part 2):417–22. doi:10.1161/HYPERTENSIONAHA.108.123729.
Schleicher M., et al. Prohibitin-1 maintains the angiogenic capacity of endothelial cells by regulating mitochondrial function and senescence. J Cell Biol. 2008 Jan 14; 180(1):101–12. doi:10.1083/jcb.200706072.
Schriewer J. M., et al. ROS-mediated PARP activity undermines mitochondrial function after permeability transition pore opening during myocardial ischemia-reperfusion. J Am Heart Assoc. 2013 Apr 18; 2(2):e000159. doi:10.1161/JAHA.113.000159.
Stride N., et al. Impaired mitochondrial function in chronically ischemic human heart. Am J Physiol Heart Circ Physiol. 2013 Mar 29. Epub. doi:10.1152/ajpheart.00991.2012.
Wallace D. C. A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine. Annu Rev Genet. 2005; 39:359–407. doi:10.1146 /annurev.genet.39.110304.095751. Yang Z., et al. Prenatal environmental tobacco smoke exposure promotes adult atherogenesis and mitochondrial damage in apoliprotein E-/— mice fed a chow diet. Circulation. 2004 Dec 14; 110(24):3715–20. doi:10.1161/01.CIR.0000149747.82157.01.
Yang Z., et al. The role of tobacco smoke induced mitochondrial damage in vascular dysfunction and atherosclerosis. Mutat Res. 2007 Aug 1; 621(1–2):61–74. doi:10.1016/j.mrfmmm.2007.02.010.
Chitaley K., Weber D. S., Webb R. C. RhoA/Rho-kinase, vascular changes and hypertension. Curr Hypertension Rep. 2001; 3:139–144. doi:10.1007/ s11906-001-0028-4
Feletou M., Vanhoutte P. M. Endothelium-dependent hyperpolarization of vascular smooth muscle cells. Acta Pharmacol Sin. 2000 Jan; 21(1):1–18. Fukata Y., Mutsuki A., Kaibuchi K. Rho-Rho-kinase pathway in smooth muscle contraction and cytoskeletal reorganization of non-muscle cells. Trends Physiol Sci. 2001 Jan; 22(1):32–9. doi:10.1016/S0165-6147(00)01596-0.
Jin L., et al. Inhibition of the tonic contraction in the treatment of erectile dysfunction. Exp Opin Ther Targets. 2003; 7(2):265–76. doi:10.1517/14728222.7.2.265.
Kao C. Y., Carsten M. E., editors. Cellular Aspects of Smooth Muscle Function. New York: Cambridge Univ. Press, 1997. Chapter 5, Mechanics of smooth muscle contraction; p. 169–208.
Kohlhaas M., Maack C. Calcium release microdomains and mitochondria. Cardiovasc Res. 2013 Feb 14; 98:259–68. Epub. doi:10.1093/cvr/cvt032. Lanza I. R., Sreekumaran Nair K. Regulation of skeletal muscle mitochondrial function: genes to proteins. Acta Physiol (Oxf). 2010 Aug; 199(4):529–47. doi:10.1111/j.1748–1716.2010.02124.x.
Li M., et al. High glucose concentrations induce oxidative damage to mitochondrial DNA in explanted vascular smooth muscle cells. Exp Biol Med. 2001 Jan 1;226(5):450–7. doi:10.1177 /153537020122600510.
Mehta S., Webb R. C., Dorrance A. M. The pathophysiology of ischemic stroke: a neuronal and vascular perspective. J Med Sci. 2002;22:53–62.
Mills T. M., et al. Inhibition of tonic contraction — a novel way to approach erectile dysfunction? J Androl. 2002 Sep 10; 23(5):S5–S9. doi:10.1002/j.1939–4640.2002.tb02294.x.
Mitchell B. M., Chitaley K. C., Webb R. C. Vascular smooth muscle contraction and relaxation. In: Izzo JL, Black HR, editors. Hypertension primer: the essentials of high blood pressure. Dallas, TX: Am. Heart Assoc.; 2003, p. 97–99.
Morgan K. G. The role of calcium in the control of vascular tone as assessed by the Ca2+ indicator aequorin. Cardiovasc Drugs Ther. 1990 Oct; 4(5):1355–62.
Ridley A. Rho: theme and variations. Curr Biol 1996; 6(10):1256–64. doi:10.1016/S0960-9822 (02)70711-2.
Sah V. P., et al. The role of Rho in G protein-coupled receptor signal transduction. Annu Rev Pharmacol Toxicol. 2000;40:459–89. doi:10.1146/ annurev.pharmtox.40.1.459.
Solaro R. J. Myosin light chain phosphatase: a Cinderella of cellular signaling. Circ Res. 2000 Aug 4; 87:173–5. doi:10.1161/01.RES.87.3.173.
Somlyo A. P., Somlyo A. V. From pharmacomechanical coupling to G-proteins and myosin phosphatase. Acta Physiol Scand. 1998 Dec; 164(4):437– 48. doi:10.1046/j.1365-201X.1998.00454.x.
Somlyo A. P., Somlyo A. V. Signal transduction by G-proteins, Rho-kinase and protein phosphatase to smooth muscle and non-muscle myosin II. J Physiol. 2000; 522(Pt 2):177–85. doi:10.1111/j.1469–7793.2000.t01-200177.x.
Somlyo A. P., et al. Pharmacomechanical coupling: the role of calcium, G-proteins, kinases and phosphatases. Rev Physiol Biochem Pharmacol. 1999; 134:201–34.
Uehata M., et al. Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature. 1997; 389:990–4. doi:10.1038/40187.
Woodrum D. A., Brophy C. M. The paradox of smooth muscle physiology. Mol Cell Endocrinol. 2001; 177(1–2):135–43. doi:10.1016/S03037207(01)00407-5.
Allen K. L., et al . Changes of respiratory chain activity in mitochondrial and synaptosomal fractions isolated from the gerbil brain after graded ischaemia. J Neurochem. 1995 May; 64(5):2222–9. doi:10.1046/j.1471–4159.1995.64052222.x.
Ankarcrona M., et al. Glutamate-induced neuronal death: a succession of necrosis or apoptosis depending on mitochondrial function. Neuron. 1995 Oct; 15(4):961–73. doi:10.1016 /0896-6273(95)90186-8.
Barbiroli B., et al. Coenzyme Q10 improves mitochondrial respiration in patients with mitochondrial cytopathies. An in vivo study on brain and skeletal muscle by phosphorous magnetic resonance spectroscopy. Cell Molec Biol. 1997; 43:741–9.
Beal M. F. Aging, energy, and oxidative stress in neurodegenerative diseases. Ann Neurol. 1995 Sep; 38(3):357–66. doi:10.1002/ana.410380304. Beal M. F., et al. Coenzyme Q10 and nicotinamide block striatal lesions produced by the mitochondrial toxin malonate. Ann Neurol. 1994; 36(6):882–8. doi:10.1002/ana.410360613.
Beal M. F., et al. Coenzyme Q10 attenuates the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) induced loss of striatal dopamine and dopaminergic axons in aged mice. Brain Res. 1998 Feb;783(1):109–14. doi:10.1016/S0006-8993(97)01192-X.
Bendahan D., et al. 31P NMR spectroscopy and ergometer exercise test as evidence for muscle oxidative performance improvement with coenzyme Q in mitochondrial myopathies. Neurology. 1992; 42(6):1203–8.
Berchtold N. C., et al. Brain gene expression patterns differentiate mild cognitive impairment from normal aged and Alzheimer’s disease. Neurobiol Aging. 2014 Sep; 35(9):1961–72. Epub 2014 Apr 2. doi:10.1016/j. neurobiolaging.2014.03.031.
Bolanos J. P., et al . Nitric oxide-mediated mitochondrial damage in the brain: mechanisms and implications for neurodegenerative diseases. J Neuro-chem.1997 Jun; 68(6):2227–40. doi:10.1046/j.1471–4159.1997.68062227.x. Bozner P., et al. The amyloid β protein induces oxidative damage of mitochondrial DNA. J Neuropathol Exp Neurol. 1997; 56:1356–62. doi:10.1097/00005072-199712000-00010.
Brookes P. S., et al. Peroxynitrite and brain mitochondria: evidence for increased proton leak. J Neurochem. 1998; 70(№ 5):2195–02.
Casley C. S, et al. Beta-amyloid inhibits integrated mitochondrial respiration and key enzyme activities. J Neurochem. 2002 Jan; 80(1):91–100. doi:10.1046/j.0022–3042.2001.00681.x.
Cassarino D. S., et al. An evaluation of the role of mitochondria in neurodegenerative diseases: mitochondrial mutations and oxidative pathology, protective nuclear responses, and cell death in neurodegeneration. Brain Res Brain Res Rev. 1999 Jan; 29(1):1–25. doi:10.1016 /S0165-0173(98)00046-0.
Chaturvedi R. K., Flint Beal M. Mitochondrial diseases of the brain. Free Radic Biol Med. 2013 Oct; 63:1–29. Epub Apr 5. doi:10.1016/j.freerad-biomed.2013.03.018.
de Moura M. B., dos Santos L. S, Van Houten B. Mitochondrial dysfunction in neurodegenerative diseases and cancer. Environ Mol Mutagen. 2010 Jun; 51(5):391–405. doi:10.1002/em.20575.
Favit A., et al. Ubiquinone protects cultured neurons against spontaneous and excitotoxin-induced degeneration. J Cereb Blood Flow Metab.1992;12(№ 4):638–45.
Fiskum G., Murphy A. N., Beal M. F. Mitochondria in neurodegeneration: acute ischemia and chronic neurodegenerative diseases. J Cereb Blood
Flow Metab. 1999 Apr; 19(4):351–69. doi:10.1097/00004647-199904000-00001.
Kuroda S., Siesjo B. K. Reperfusion damage following focal ischemia: pathophysiology and therapeutic windows. Clin Neurosci. 1997; 4(4):199–212.
Leist M., Nicotera P. Apoptosis, excitotoxicity, and neuropathology. Exp Cell Res. 1998; 239(2): 183–201. doi:10.1006/excr.1997.4026.
Liu J., et al. Memory loss in old rats is associated with brain mitochondrial decay and RNA/ DNA oxidation: partial reversal by feeding acetyl-L-carnitine and/or R-alpha-lipoic acid. Proc Natl Acad Sci U S A. 2002 Feb 19; 99(4):2356–61. doi:10.1073/pnas.261709299.
Love S. Oxidative stress in brain ischemia. Brain Pathol. 1999 Jan; 9(1):119– 31. doi:10.1111 /j.1750–3639.1999.tb00214.x.
Matsumoto S., et al. Blockade of the mitochondrial permeability transition pore diminishes infarct size in the rat after transient middle cerebral artery occlusion. J Cereb Blood Flow Metab. 1999; 19(№ 7):736–41.
Matthews R. T., et al. Coenzyme Q10 administration increases brain mitochondrial concentrations and exerts neuroprotective effects. Proc Natl Acad Sci U S A. 1998 Jul 21; 95 (15):8892–7.
Mazzio E., et al. Effect of antioxidants on L-glutamate and N-methyl-4-phenylpyridinium ion induced-neurotoxicity in PC12 cells. Neurotoxicology. 2001; 22:283–8.
Mecocci P., et al. Oxidative damage to mitochondrial DNA shows marked age-dependent increases in human brain. Ann Neurol. 1993 Oct; 34(4):609–16. doi:10.1002/ana.410340416.
Mordente A., et al. Free radical production by activated haem proteins: protective effect of coenzyme Q. Molec Aspects Med. 1994; 15(Suppl S109–S115).
Murphy A. N., Fiskum G., Beal F. Mitochondria in neurodegeneration: bioenergetic function in cell life and death. J Cereb Blood Flow Metab. 1999; 19(№ 3):231–45.
Musumeci O., et al. Familial cerebellar ataxia with muscle coenzyme Q10 deficiency. Neurology. 2001 Apr 10; 56(7):849–55.
Nam M. K., et al. Essential roles of mitochondrial depolarization in neuron loss through microglial activation and attraction toward neurons. Brain Res. 2013 Apr 10; 1505:75–85. Epub Feb 12. doi:10.1016/j. brainres.2013.02.005.
Novelli A., et al. Glutamate becomes neurotoxic via the N-methyl-Daspartate receptor when intracellular energy levels are reduced. Brain Res.1988 Jun 7; 451(1–2):205–12. doi:10.1016/0006-8993(88)90765-2. Ristow M., et al. Frataxin activates mitochondrial energy conversion and oxidative phosphorylation. Proc Natl Acad Sci U S A. 2000; 97(№ 22):12239–43. doi:10.1073 /pnas.220403797.
Читать дальшеИнтервал:
Закладка:
